Patient-Centered Research

  • Real-World Evidence

    We offer leadership in the design and execution of studies to meet payer and regulator evidence requirements.

  • Patient-Centered Research

    We represent a unique combination of scientific disciplines, including psychometrics, economics, decision analysis, epidemiology, biostatistics, psychology and public health.

  • Medical Writing

    Continuity of Quality and Scientific Rigor Across the Spectrum of Your Writing and Communication Needs

  • Pragmatic Studies

    Innovative approaches to randomized trials can bridge the intersection of observational RWE and the conventional RCT and provide

  • Interventional Studies

    We are experience in designing global, regional and single country studies in the post-approval space

  • Market Access

    We can help you navigate complex evidence requirements and anticipate and overcome payer barriers to help you achieve optimal price and access.

  • Real-World Data

    We can help you collect Real-world data high efficiency with IT technologies


Patients are key stakeholders in all aspects of medical decision-making, and there is a growing emphasis on patient engagement and patient-centered evidence among regulators and payers. Evidera’s patient-centered researchers represent a unique combination of scientific disciplines, including psychometrics, economics, decision analysis, epidemiology, biostatistics, psychology and public health. We develop and evaluate clinical outcome assessments to support labeling and promotional claims. We are your partner for evaluating patient, clinician, and caregiver outcomes, utilities and preferences, adherence and other customized prospective observational study needs.


High quality, patient-centered data is becoming increasingly imperative for regulators and other stakeholders to understand whether a drug provides treatment or safety benefit. Evidera designs and implements strategies for outcome evaluation, including ClinROs, PROs, ObsROs and/or PerfOs that meet regulatory and stakeholder demands. We take an evidence-based approach to instrument development, driven by extensive experience measuring health outcomes across a variety of conditions and diseases. We help you understand the issues and design your program from concept identification and development through platform selection, instrument design and psychometric testing, and we provide ongoing support during implementation and analyses.


  • Instrument Development and Psychometric Evaluation
  • Outcomes Strategy
  • Outcomes Evidence Dossier
  • Health Utilities Studies
  • Clinical Trials Support
  • Electronic Clinical Outcomes Assessment (eCOA)
  • Technology (m/e-health) Validation Studies
  • Advanced Psychometric and Statistical Modeling Services
  • Regulatory Support
  • Scientific Dissemination


Now more than ever, patients are active participants in their own care. Patient-centric healthcare models are becoming the new norm, with services designed to incorporate and embrace patients’ wants, needs, and preferences. Evidera provides services that elucidate the patient experience at various stages in the product lifecycle to inform a patient-focused drug development strategy. Patient-centered services are designed around the unique needs of a program to facilitate the understanding of the patient experience as it relates to current unmet needs, the burden of illness, impacts of a disease, patient-defined meaningful endpoints, and patient-centered trial design. Evidera serves in leadership roles in several professional society and academic special interest working groups focused on developing best practices and recommendations for how to facilitate the engagement of patients in medical product development. We provide new and innovative approaches to working with patients, and can help you design patient experience activities to ensure your medical product development strategy is patient-focused.



Most recognize that patient preferences have an important role to play in healthcare decision making, although it is only recently that decision makers have shown interest in quantitative methods for eliciting patient preferences. Data on patients’ trade-offs can be used to generate decision relevant information, including: the minimum acceptable benefit to offset treatment risks; the maximum acceptable risk that would be justified by treatment benefits; overall benefit-risk profile; willingness to pay; and the probability that a patient selects or adheres to a particular treatment. With one of the largest in-house teams, and a unique combination of experience in both preference elicitation and decision analysis, Evidera has the expertise to ensure you generate preference information that meets the needs of decision makers.


  • Preference Elicitation (e.g., discrete choice, best-worst scaling, threshold analysis, swing weighting)
  • Health Utilities Studies
  • Patient-Centered Benefit Risk Assessment
  • Uncertainty Analysis
  • Experience Interacting with Regulators


Latest News

  • 20
  • MedSci participated in the 18th annual meeting of Chinese Society of Clinical Oncology (CSCO) from 16-20 Sept., 2015. In attendance were about 6000...
  • 31
  • There are many variations of passages of Lorem Ipsum available, but theses majority have suffered alteration in some form, by injected humour, or...